Skip to content

Opening book details…

Can I read The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma on EtoBox?

The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma by Juan Garcia Valero; Alba Matas-Céspedes; Fabián Arenas; Vanina Rodriguez; Joaquim Carreras; Neus Serrat; Martina Guerrero-Hernández; Anella Yahiaoui; Olga Balagué; Silvia Martin; Cristina Capdevila; Lluis Hernández; Laura Magnano; Alfredo Rivas-Delgado; Stacey Tannheimer; Maria C. Cid; Elías Campo; Armando López-Guillermo; Dolors Colomer; Patricia Pérez-Galán is a Medicine article available to read on EtoBox.

What is The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma about?

## Abstract Microenvironment contributes to follicular lymphoma (FL) pathogenesis and impacts survival with macrophages playing a controversial role. In the present study, using FL primary samples and HK follicular dendritic cells (FDC) to mimic the germinal center, together with mouse models, we have analyzed the three-way crosstalk of FL-FDC-macrophages and derived therapeutic opportunities. Ex vivo primary FL-FDC co-cultures (n = 19) and in vivo mouse co-xenografts demonstrated that FL-FDC crosstalk favors tumor growth and, via the secretion of CCL2 and CSF-1, promotes monocyte recruitment, differentiation, and polarization towards an M2-like protumoral phenotype. Moreover, FL-M2 co-cultures displayed enhanced angiogenesis, dissemination, and immunosuppression. Analysis of the CSF-1/CSF-1R pathway uncovered that CSF-1 was significantly higher in serum from grade 3A FL patients, and that high CSF-1R expression in FL biopsies correlated with grade 3A, reduced overall survival and risk of transformation. Furthermore, CSF-1R inhibition with pexidartinib (PLX3397) preferentially affected M2-macrophage viability and polarization program disrupting FL-M2 positive crosstalk. In vivo CSF

Who reads The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Juan Garcia Valero; Alba Matas-Céspedes; Fabián Arenas; Vanina Rodriguez; Joaquim Carreras; Neus Serrat; Martina Guerrero-Hernández; Anella Yahiaoui; Olga Balagué; Silvia Martin; Cristina Capdevila; Lluis Hernández; Laura Magnano; Alfredo Rivas-Delgado; Stacey Tannheimer; Maria C. Cid; Elías Campo; Armando López-Guillermo; Dolors Colomer; Patricia Pérez-Galán
Publisher
Springer Science and Business Media LLC
Published
2021
Language
EN
Field
Medicine (Health Sciences)

More by Juan Garcia Valero; Alba Matas-Céspedes; Fabián Arenas; Vanina Rodriguez; Joaquim Carreras; Neus Serrat; Martina Guerrero-Hernández; Anella Yahiaoui; Olga Balagué; Silvia Martin; Cristina Capdevila; Lluis Hernández; Laura Magnano; Alfredo Rivas-Delgado; Stacey Tannheimer; Maria C. Cid; Elías Campo; Armando López-Guillermo; Dolors Colomer; Patricia Pérez-Galán

Browse all works by Juan Garcia Valero; Alba Matas-Céspedes; Fabián Arenas; Vanina Rodriguez; Joaquim Carreras; Neus Serrat; Martina Guerrero-Hernández; Anella Yahiaoui; Olga Balagué; Silvia Martin; Cristina Capdevila; Lluis Hernández; Laura Magnano; Alfredo Rivas-Delgado; Stacey Tannheimer; Maria C. Cid; Elías Campo; Armando López-Guillermo; Dolors Colomer; Patricia Pérez-Galán